Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
Robert Gniadecki, B Bang,
L E Bryld
, L Iversen, S Lasthein,
Lone Skov
Department of Clinical Medicine
189
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Biological Factors
100%
Psoriasis
92%
Safety
54%
Survival
52%
Ustekinumab
40%
Pharmaceutical Preparations
38%
Adalimumab
25%
Etanercept
25%
Infliximab
23%
Confidence Intervals
20%
Biological Products
13%
Tumor Necrosis Factor-alpha
9%
Odds Ratio
8%
Biological Therapy
7%
Population Density
7%
Denmark
7%
Statistical Factor Analysis
5%
Registries
5%
Survival Rate
5%
Observation
4%
Therapeutics
2%